Juárez-Leon Valeria, Calderón-Solano Delahnie, Poterico Julio A, Ybaseta-Medina Jorge, Azañedo Diego, Torres-Román J Smith
Universidad Científica del Sur, Lima, Peru.
Universidad de Huánuco, Huánuco, Peru.
BMC Public Health. 2025 Jul 3;25(1):2334. doi: 10.1186/s12889-025-23228-8.
In 2022, cervical cancer was the second most common neoplasia among women in Peru, with 4809 cases and 2545 deaths reported. Infection with human papillomavirus (HPV) is a key factor in the development of this disease. Vaccination is the primary strategy for HPV prevention. Although HPV vaccination coverage has improved, evaluating acceptance profiles is crucial for effectively monitoring public immunization policies. We aimed to determine the associated factors with parental acceptance of the HPV vaccine in girls from Peru.
An observational, analytical, and cross-sectional study was conducted with a sample of 204 parents of girls and adolescents aged 9 to 19 years in Metropolitan Lima. The dependent variable was acceptance of the HPV vaccine, while the independent variables included demographic data, level of knowledge about HPV, and socioeconomic and cultural factors.
A total of 204 parents participated in the study. Overall, 61.3% expressed willingness to vaccinate their daughters against HPV. Factors significantly associated with vaccine acceptance in the bivariate analysis included being a mother, being married, residing in the South-Central region, having a high monthly income, possessing private or public health insurance, and having a higher level of education. In both bivariate and multivariable analyses, having a daughter previously vaccinated against HPV was significantly associated with HPV vaccine acceptance, and remained the only independent predictor in the adjusted model (aPR = 1.25, 95% CI: 1.03–1.53, = 0.023). Knowledge level about HPV was not significantly associated with vaccine acceptance in the adjusted model.
Prior experience with HPV vaccination was the strongest predictor of parental acceptance. Increasing awareness and addressing misconceptions through educational campaigns may enhance vaccine uptake.
2022年,宫颈癌是秘鲁女性中第二常见的肿瘤,报告病例4809例,死亡2545例。人乳头瘤病毒(HPV)感染是该疾病发生的关键因素。接种疫苗是预防HPV的主要策略。尽管HPV疫苗接种覆盖率有所提高,但评估接受情况对于有效监测公共免疫政策至关重要。我们旨在确定秘鲁女孩父母接受HPV疫苗的相关因素。
对利马大都会9至19岁女孩和青少年的204名父母进行了一项观察性、分析性横断面研究。因变量是对HPV疫苗的接受情况,自变量包括人口统计学数据、对HPV的了解程度以及社会经济和文化因素。
共有204名父母参与了研究。总体而言,61.3%的父母表示愿意为女儿接种HPV疫苗。在双变量分析中,与疫苗接受情况显著相关的因素包括母亲身份、已婚、居住在中南部地区、月收入高、拥有私人或公共医疗保险以及教育程度较高。在双变量和多变量分析中,女儿之前接种过HPV疫苗与HPV疫苗接受情况显著相关,并且在调整模型中仍然是唯一的独立预测因素(调整后风险比=1.25,95%置信区间:1.03-1.53,P=0.023)。在调整模型中,对HPV的了解程度与疫苗接受情况没有显著关联。
HPV疫苗接种的既往经历是父母接受程度的最强预测因素。通过开展教育活动提高认识并消除误解可能会提高疫苗接种率。